Campaigners launch legal challenge to NHS drug price control changes demanded by Trump
From the article
You might also wanna read
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicin
theguardian.com·5d ago
Five EU countries seek unified response to US and pharma pressure on drug pricing
Five EU countries are calling for a united European response to pressure from the U.S. and pharmaceutical companies demanding higher drug pr
politico.eu·28d ago
Starmer's US pharma deal criticized as costly threat to NHS and public health
Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law facilitating a US medicine import deal
theguardian.com·7d ago
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·6d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·6d agoStarmer's US pharma deal criticized as costly threat to NHS funding and public health
Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law enabling a US pharma deal that will harm the NHS by costi
theguardian.com·6d agoStarmer's US pharma deal criticized as costly, harmful to NHS, and a democratic failure
Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law enabling a US pharma deal that will ha
theguardian.com·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.